抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
Research Grade Lerdelimumab
All
TD-HX861016_1.jpg
TD-HX861016_2.jpg
- Catalog： TD-HX861016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： CAT-152, Trabio, CAS: 285985-06-0
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Lerdelimumab
| Catalog No. | TD-HX861016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Human |
| Isotype | IgG4-lambda |
| Expression system | Mammalian Cells |
| Species | Human |
| Clonality | Monoclonal |
| Target | Glioblastoma-derived T-cell suppressor factor, TGF-beta-2, LAP, G-TSF, TGFB2, Cetermin, Transforming growth factor beta-2 proprotein |
| Endotoxin level | Please contact with the lab for this information. |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P61812 |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternate Names | CAT-152, Trabio, CAS: 285985-06-0 |
| Background | Lerdelimumab (CAT-152) is an IgG4 human anti-TGF-β2 recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research. |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
|
|
Detects TGFB2 in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Lerdelimumab. |